Atezolizumab-induced psoriasiform drug eruption successfully treated with ixekizumab: a case report and literature review
Dermatology Online Journal · 2023
DOI: 10.5070/d329160215 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Dermatology Online Journal, 2023. Verfasst von L Gleason und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. neda.nikbakht@jefferson.edu. Hauptthemen laut MEDLINE: Psoriasis, Drug Eruptions, Exanthema. Die Arbeit wurde bisher 14-mal zitiert (Crossref).
Abstract (Originalsprache)
Immune-related cutaneous adverse events (ircAE) are commonly seen with immune checkpoint inhibitors such as atezolizumab. Atezolizumab-induced psoriasis has been previously reported as an ircAE, especially in patients with pre-existing psoriasis. The severity of the reaction influences treatment of the cutaneous eruption. Biologics should be considered as a treatment option for severe refractory psoriasiform eruptions even in patients with complex medical conditions like chronic infections and malignancy. This is the first reported case of successful treatment of atezolizumab-induced psoriasiform eruption with ixekizumab, a neutralizing IL17A monoclonal antibody, to the best of our knowledge. Herein, we present a 63-year-old man with a history of human immunodeficiency virus and psoriasis who presented with atezolizumab-induced psoriasiform eruption while being treated for metastatic hepatocellular carcinoma. After initiating ixekizumab, atezolizumab was restarted without cutaneous eruption.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. neda.nikbakht@jefferson.edu.
Zitieren
APA
Gleason, L., Hunter, E., Cohen, A., Suriano, J., & Nikbakht, N. (2023). Atezolizumab-induced psoriasiform drug eruption successfully treated with ixekizumab: a case report and literature review. Dermatology Online Journal. https://doi.org/10.5070/d329160215
Vancouver
Gleason L, Hunter E, Cohen A, Suriano J, Nikbakht N. Atezolizumab-induced psoriasiform drug eruption successfully treated with ixekizumab: a case report and literature review. Dermatology Online Journal. 2023. doi:10.5070/d329160215
BibTeX
@article{Gleason2023,
author = {Gleason, L and Hunter, E and Cohen, A and Suriano, J and Nikbakht, N},
title = {Atezolizumab-induced psoriasiform drug eruption successfully treated with ixekizumab: a case report and literature review},
journal = {Dermatology Online Journal},
year = {2023},
doi = {10.5070/d329160215}
}
EUVIMED